Nutex Health Inc.
NUTXNasdaqIndustrials · Services-Business Services, NEC · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $875.3M | $479.9M | $247.6M | $219.3M | $18.8M | $1.6M |
| Operating income | $275.6M | $130.7M | −$31.8M | −$406.6M | −$9.0M | $1.4M |
| Net income | $70.8M | $52.1M | −$45.8M | −$424.8M | −$13.7M | −$5.7M |
| Total assets | $918.5M | $655.3M | $398.2M | $431.8M | $85.7M | $169,857 |
| Total liabilities | $495.1M | $466.8M | $319.1M | $311.4M | $10.6M | $1.3M |
| Equity | $329.4M | $132.4M | $61.5M | $95.9M | $114.7M | −$1.1M |
| EPS (diluted) | $10.48 | $9.69 | $-10.39 | $-0.67 | $0.22 | $0.18 |
| Shares out. | 5.5M | 745.4M | 650.9M | 48.4M | 39.3M | 4.6M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 31.5%
- Net margin
- 8.1%
- Return on equity
- 21.5%
- Return on assets
- 7.7%
- Return on capital (ROCE)
- 36.2%
- Liabilities / assets
- 53.9%
- Debt / equity
- 1.50×
- Book value / share
- $59.59
- Revenue growth (YoY)
- 82.4%
- Net income growth (YoY)
- 35.9%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 4.42safe
- Accruals / assets
- −19.3%clean
- Piotroski F-Score
- 8/9strong
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 6 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating margin is positive
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Nov 17, 2025
- NT 10-Qmissed a reporting deadline ↗Aug 14, 2025
- NT 10-Kmissed a reporting deadline ↗Mar 15, 2024
- NT 10-Qmissed a reporting deadline ↗May 11, 2023
- NT 10-Kmissed a reporting deadline ↗Mar 2, 2023
- NT 10-Qmissed a reporting deadline ↗Nov 15, 2022
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Pertento Partners LlpPassive (13G)May 7, 2026
- Blackrock, Inc.Passive (13G)Apr 27, 2026
- Topline Capital Management, LlcPassive (13G)Oct 29, 2025
- Highbridge Capital Management LlcPassive (13G)Feb 7, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 916,308 | 5.0 | -8.1% |
| Apr 30, 2026 | 996,714 | 5.3 | +4.2% |
| Apr 15, 2026 | 956,778 | 5.3 | -3.8% |
| Mar 31, 2026 | 994,341 | 5.5 | +3.1% |
| Mar 13, 2026 | 964,253 | 3.6 | +3.9% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsApr 30, 2026
- Shareholder voteApr 23, 2026
- Results of operationsMar 5, 2026
- Other material eventNov 24, 2025
- Results of operationsNov 19, 2025
- Results of operationsNov 18, 2025
- Results of operationsNov 18, 2025
- Results of operationsNov 18, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 4PRIMARY DOCUMENTMay 29, 2026
- SCHEDULE 13G/AMay 7, 2026
- 8-KApr 30, 2026
- 10-QApr 30, 2026
- SCHEDULE 13GApr 27, 2026
- 4PRIMARY DOCUMENTApr 24, 2026
- 4PRIMARY DOCUMENTApr 24, 2026
- 4PRIMARY DOCUMENTApr 24, 2026
- 4PRIMARY DOCUMENTApr 24, 2026
- 8-KApr 23, 2026
- 4PRIMARY DOCUMENTApr 10, 2026
- 4PRIMARY DOCUMENTMar 24, 2026
- 4PRIMARY DOCUMENTMar 23, 2026
- 4PRIMARY DOCUMENTMar 23, 2026
- 4PRIMARY DOCUMENTMar 18, 2026